| abstract |
The present invention relates to compounds of formula (I), wherein the substituents are as described in claim 1. It has been found that the compounds of formula (I) of the present invention are modulators of beta-amyloid, and therefore they can be used for the treatment or prevention of diseases associated with the deposition of beta-amyloid in the brain, in particular Alzheimer's and other diseases such as cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D), multi-infarct dementia, dementia pugilistica, and Down syndrome. |